Effect of a Persian Medicine product on iron deficiency anemia in women of reproductive age

Effect of a Persian Medicine product on iron deficiency anemia in women of reproductive age (15-45 years old) : A randomized controlled trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191216045752N2

Enrollment

Registered

2020-02-04

Start date

2019-12-31

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron deficiency anemia. Iron deficiency anemia, unspecified

Interventions

Intervention 1: Intervention group:The intervention group will be given 1 tablet of Iron Plus daily. This drug will be produced by NIAC Co. of Golestan Province and contains 50 mg of elemental iron. I

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Hemoglobin385 µg/dl Transferrin saturation <10% Ferritin<12 mg/L

Exclusion criteria

Exclusion criteria: Using steroids, tetracycline, quinolones and anti acids Pregnancy Breastfeeding Underlying diseases

Design outcomes

Primary

Measure	Time frame
Hemoglobin. Timepoint: 0, 4 and 8 week after starting the study. Method of measurement: CBC test.;Ferritin. Timepoint: 0, 4 and 8 week after starting the study. Method of measurement: ferritin test.	—

Secondary

Measure	Time frame
RBC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCV. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCH. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCHC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;Hematocrit. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;Serum iron. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: serum iron test.;TIBC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: TIBC test.;Drug side effects. Timepoint: 2 and 6 weeks after starting the study. Method of measurement: questionnaire.	—

Measure

Time frame

RBC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCV. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCH. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;MCHC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;Hematocrit. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: CBC.;Serum iron. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: serum iron test.;TIBC. Timepoint: 0, 4 and 8 weeks after starting the study. Method of measurement: TIBC test.;Drug side effects. Timepoint: 2 and 6 weeks after starting the study. Method of measurement: questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHoorieh mohammadi Kenari

Research Institute for Islamic and Complementary Medicine

mohammadikenari.h@iums.ac.ir+98 21 5558 0388

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026